Startups
Edit
Western Oncolytics Ltd.
http://westernoncolytics.com/Last activity: 21.06.2014
Probably Closed
Western Oncolytics was founded in 2014 to bring cutting-edge, next-generation oncolytic immunotherapies to cancer patients everywhere. Spun out of University of Pittsburgh’s world-class oncolytic virus and immunotherapy research programs, our company is now advancing multiple therapeutic candidates towards the clinic and occupies over 18,000 square feet of lab space in our Pittsburgh headquarters.
We are engineering an optimized vaccinia virus-based oncolytic platform which can be combined with multiple transgenes to create versatile and differentiated immunotherapies. Our development programs are designed to be safe, potent, and systemically deliverable to treat cancer patients across a variety of tumor types. In 2016, we formed a strategic partnership with Pfizer for our lead preclinical program, WO-12.
We are engineering an optimized vaccinia virus-based oncolytic platform which can be combined with multiple transgenes to create versatile and differentiated immunotherapies. Our development programs are designed to be safe, potent, and systemically deliverable to treat cancer patients across a variety of tumor types. In 2016, we formed a strategic partnership with Pfizer for our lead preclinical program, WO-12.
Overview
Location
United States, Pennsylvania, Pittsburgh
Employees
1-10
Total raised
$275K
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 20, 2014 | Western Oncolytics Inks $275K Seed Funding | CLEVELAND, OH, Biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. >> Click here for more funding data on Western Oncolytics >> To export Western Oncolytics funding data to... |
| Jun 19, 2014 | Western Oncolytics Closes $275K Seed Funding | Western Oncolytics Ltd., a Cleveland, OH-based biotech company specializing in immuno-oncolytic cancer therapies, closed a $275k seed funding. The company intends to use the funds for clinical trials and execute initial manufacturing for it... |
| Cleveland biotech closes $275,000 in seed funding | Cleveland biotech company Western Oncolytics is developing an immune-oncolytic therapy licensed by the University of Pittsburgh which combines oncolytic virus and gene therapy technologies to rid cancer cells of the ability to survive in th... |
Reviews 0
FAQ about Western Oncolytics Ltd.
When was Western Oncolytics Ltd. founded?
Western Oncolytics Ltd. was founded in 2014.
How much funding has Western Oncolytics Ltd. raised?
Western Oncolytics Ltd. has raised $275K in total across 1 funding round.
What has the press written about Western Oncolytics Ltd.?
Parsers VC has collected 4 articles mentioning Western Oncolytics Ltd., among them “Western Oncolytics Inks $275K Seed Funding” (Jun 20, 2014) and “Western Oncolytics Closes $275K Seed Funding” (Jun 19, 2014).
Is Western Oncolytics Ltd. still active?
Western Oncolytics Ltd. is probably closed: its latest activity on Parsers VC dates from Jun 21, 2014.